Evidence Builds The SURMOUNT-OSA trial, funded by Eli Lilly, added to this evidence
How this may help: Improves blood flow to muscles Supports metabolic activity Reduces stress hormones May improve how cells use glucose When circulation improves, muscles can absorb sugar from the blood more efficiently, which improves insulin sensitivity
GLP-1 injections are generally prescribed to individuals who are struggling with obesity or who need to lose weight to manage type 2 diabetes or other weight-related health conditions
Published Phase 2 clinical trial data used doses of 1mg, 4mg, 8mg, and 12mg administered weekly via subcutaneous injection
Introducing Akkermansia into this depleted environment can lead to overgrowth, excessive mucus degradation, and worsened intestinal permeability